首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia.
【2h】

Successful hematopoietic reconstitution with transplantation of erythrocyte-depleted allogeneic human umbilical cord blood cells in a child with leukemia.

机译:在患有白血病的儿童中通过贫血的同种异体人类脐带血细胞移植成功进行造血重建。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cord blood, a potent source of hematopoietic stem cells, has been shown to successfully reconstitute hematopoiesis following allogeneic transplantation in a variety of disorders. A major drawback of cord blood has been the risk of transfusion reactions in ABO blood group incompatibility and drastic reduction in the stem cell pool if the cord blood is manipulated to remove red cells prior to cryopreservation or after thawing. This report describes an erythrocyte depletion method employing 3% gelatin-induced erythrocyte sedimentation for the selective removal of red cells from cord blood. The red cell-depleted fraction was shown to be enriched in progenitor cells and in cells secreting hematopoietic cytokines interleukin 3, granulocyte/macrophage colony-stimulating factor, and interleukin 6; a major source for cytokines was from cord T cells. This preparative technique was employed to separate out red cells from cord blood of an infant delivered by cesarean section who had an 8-year-old sibling with leukemia. Histocompatibility testing of cord cells revealed complete matching with the patient. A cord cell transplant of cryopreserved and thawed cells consisting of 4 x 10(7) nucleated cells per kg was administered to the patient following myeloablative chemotherapy. The patient's quick hematologic recovery and 9-month disease-free period to date suggest that 3% gelatin separation of erythrocytes is a simple method that can be successfully used for transplanting cord cells for malignantonmalignant diseases.
机译:脐血是造血干细胞的有效来源,已显示出在各种疾病的同种异体移植后可以成功地重建造血功能。脐带血的主要缺点是,如果在冷冻保存之前或解冻后对脐带血进行操作以去除红细胞,则可能会导致ABO血型不相容的输血反应风险以及干细胞池急剧减少。该报告描述了一种红细胞耗竭方法,该方法采用3%明胶诱导的红细胞沉降来从脐带血中选择性去除红细胞。贫血的红细胞部分富含祖细胞和分泌造血细胞因子白介素3,粒细胞/巨噬细胞集落刺激因子和白介素6的细胞。细胞因子的主要来源是脐带T细胞。这项制备技术用于从剖宫产分娩的婴儿中分离出红细胞,该婴儿的剖腹产是一名8岁的患有白血病的兄弟姐妹。脐带细胞的组织相容性测试显示与患者完全匹配。在清髓性化学疗法后,对患者进行每公斤4 x 10(7)个有核细胞组成的冻存和解冻细胞的脐带细胞移植。患者的血液学快速恢复和迄今9个月的无病期表明,红细胞的3%明胶分离是一种简单的方法,可以成功地用于移植恶性/非恶性疾病的脐带细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号